Skip to content

Assesment of Multiomics Profiles in Health and Disease.

Assesment of Multiomics Profiles in Health and Disease - Corelation With the Disease Phenotype.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04427163
Acronym
ENIGMA
Enrollment
1100
Registered
2020-06-11
Start date
2018-09-01
Completion date
2029-03-30
Last updated
2026-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genetic Predisposition to Disease

Keywords

genomic profile, disease phenotype, proteomic profile, metabolomic profile, transcriptomic profile

Brief summary

This study will determine reference genomic, transcriptomic, proteomic and metabolomic profiles in Czech population and will evaluate its correlation with the disease phenotype.

Detailed description

This study will determine reference genomic, transcriptomic, proteomic and metabolomic profiles in Czech population. Initially, there will be 1000 healthy volunteers, with the planned expansion to 10.000 participants (healthy volunteers and patients with different types of disease). Formation of the reference database of healthy volunteers and their parameters will allow a correct interpretation of the potential pathological findings in patients. It is very important to obtain healthy controls from the region of the Czech Republic, Central Europe respectively; since it is not possible to reliably compere ethnically and geographically diverse populations, which have generated in a different context and where the diseases manifest with other etiology ad phenotype. Although, in the limited measure, the similar molecular data exist in foreign databases, these are not compiled from the inhabitants of the Czech Republic, Central Europe not even from Slavic population. Study participants may volunteer for archiving of remaining biological materials for future studies.

Interventions

Nucleic acids sequencing, presence of proteins and metabolites.

OTHERHealth status

Health status will be examined by a physician and subject will complete a health status questionnaire.

OTHERRace and ethnicity

Subject will complete race and ethnicity questionnaire to make sure subjects are from the Czech population.

Sponsors

The Institute of Molecular and Translational Medicine, Czech Republic
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 68 Years
Healthy volunteers
Yes

Inclusion criteria

* age 18 - 68 years * (for the first 1100 subjects): * healthy volunteers without genetically dependent disease and without such a disease in a family * healthy volunteer without the preliminary evidence of civilizational diseases such as hypertension, diabetes, autoimmune and tumor diseases or acute infectional diseases; clinically manifesting cardiovascular or pulmonary disability. * subject without permanent of long-term medication in the time of biological sampling.

Exclusion criteria

* not complying with inclusion criteria

Design outcomes

Primary

MeasureTime frameDescription
Whole Genome (Exom) Sequencing of the Healthy Volunteers - establishment of the HEALTHY VOLUNTEER REFERENCE GENOME (min. 1000 individuals)72 monthsEstablishment of the Healthy Volunteers Whole Genome (Exom) Reference Database typical for the population of the Czech Republic/Central Europe.
Whole Genome (Exom) Sequencing of the patient groups with different diseases and their comparison to the HEALTHY VOLUNTEER REFERENCE GENOME72 monthsWhole Genome (Exom) Sequencing of the patient populations presenting various diseases. Based on the comparison with the HEALTHY VOLUNTEER REFERENCE GENOME - determination of various genetic polymorphisms (single nucleotide polymorphisms, insertions, deletions, inversions, copy-number variations etc.) and giving these into correlation with disease phenotypes.

Secondary

MeasureTime frameDescription
Evaluation of the correlation with the disease phenotype72 monthsBased on the reference database of healthy volunteers in the Czech Republic a potential correlations will be evaluated among genomic, proteomic and metabolomic profiles of patients and the disease phenotypes.

Countries

Czechia

Contacts

CONTACTMarian Hajduch, MD, PhD.
marian.hajduch@upol.cz+420585632083
CONTACTMichaela Bendova, MSc.
michaela.bendova@upol.cz+420585632050
STUDY_DIRECTORMarian Hajduch, MD, PhD.

IMTM, Palacky University in Olomouc, Faculty of Medicine and Dentistry

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026